clinical trial · NCT06270511
A Study to Investigate Different Formulations of S-337395 in Healthy Adult Participants
Shionogi·phase1·completed·n = 50
Healthy VolunteersS-337395Placebo
brief summary
The aim of this study is to investigate different formulations of S-337395.
started
Mar 13, 2024
primary completion
May 30, 2024
completion
Jun 19, 2024
last updated
Jul 10, 2024
detailed description
This single-center study comprises an open-label, randomized, crossover study, and a double-blinded, placebo-controlled, randomized, multiple-dose study to examine the relative bioavailability, food effect, pharmacokinetics, safety, and tolerability of different formulations of S-337395.
official title
A Phase 1, 2-Part Study to Evaluate the Relative Bioavailability of and Food-Effect on Pharmacokinetics of Different Formulations of S-337395, and to Assess the Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of S-337395 in Healthy Adult Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol